ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
169 hedge funds and large institutions have $1B invested in Array Biopharma Inc in 2016 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 14 closing their positions.
Holders
169
Holders Change
+41
Holders Change %
+32.03%
% of All Funds
4.52%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
56
Increased
46
Reduced
40
Closed
14
Calls
$8.53M
Puts
$11.2M
Net Calls
-$2.65M
Net Calls Change
-$3.35M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$165M |
| 2 |
2
Franklin Resources
San Mateo,
California
|
$29.2M |
| 3 |
3
Millennium Management
New York
|
$37M |
| 4 |
O
4
OrbiMed
New York
|
$95.7M |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$13M |
Top Sellers
| 1 |
DM
1
Deerfield Management
New York
|
$11.1M |
| 2 |
RG
2
Redmile Group
San Francisco,
California
|
$112M |
| 3 |
BI
3
BVF Inc
San Francisco,
California
|
$43.6M |
| 4 |
BBA
4
Baker Bros. Advisors
New York
|
$22.3M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$6.19M |
